Advantages and disadvantages of current prophylactic vaccines against HPV. [electronic resource]
- Archives of medical research Aug 2009
- 471-7 p. digital
Publication Type: Journal Article; Review
1873-5487
10.1016/j.arcmed.2009.08.005 doi
Drug Approval Female Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Humans Incidence Papillomaviridae--immunology Papillomavirus Infections--complications Papillomavirus Vaccines--economics Randomized Controlled Trials as Topic Risk Factors Treatment Outcome Uterine Cervical Neoplasms--prevention & control